Ftse Mib
34.186,18
0,07%
DAX
19.909,14
-0,25%
S&P 500
5.881,63
-0,43%
NASDAQ
19.310,79
-0,90%
Bitcoin
93.563,27
0,19%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Cytokinetics Inc (CYTK) Cytokinetics Inc (CYTK) Notizie

Cytokinetics Inc

CYTK
47,04
-0,11 (-0,23%)
01 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
23/12/202413:30GLOBECytokinetics Announces European Medicines Agency Validation..
20/12/202406:00GLOBECytokinetics Announces Sanofi Acquired Rights to Develop and..
17/12/202401:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202422:38EDGAR2Form 8-K - Current report
16/12/202422:13EDGAR2Form 144 - Report of proposed sale of securities
12/12/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/12/202423:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/12/202422:06EDGAR2Form 144 - Report of proposed sale of securities
05/12/202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202422:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/12/202422:00GLOBECytokinetics Announces Inducement Grants Under Nasdaq..
03/12/202413:30GLOBECytokinetics Announces Start of COMET-HF, a Confirmatory..
03/12/202400:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202422:01EDGAR2Form 144 - Report of proposed sale of securities
02/12/202422:00GLOBECytokinetics to Participate in December Investor Conferences
02/12/202413:30GLOBECytokinetics Announces FDA Acceptance of New Drug..
27/11/202401:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/11/202423:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/11/202422:09EDGAR2Form 144 - Report of proposed sale of securities
25/11/202422:10EDGAR2Form 144 - Report of proposed sale of securities
19/11/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/11/202412:02EDGAR2Form 8-K - Current report
19/11/202408:30GLOBECytokinetics and Bayer Announce Exclusive Licensing..
18/11/202422:31EDGAR2Form 144 - Report of proposed sale of securities
16/11/202415:00GLOBECytokinetics Presents New Data Relating to Aficamten and..
14/11/202419:28EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
13/11/202423:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/11/202422:08EDGAR2Form 144 - Report of proposed sale of securities
12/11/202422:00GLOBECytokinetics to Participate in the 2024 Jefferies London..
11/11/202413:30GLOBECytokinetics Announces Initiation of Phase 1 Clinical Study..
07/11/202422:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202422:05EDGAR2Form 8-K - Current report
06/11/202422:00GLOBECytokinetics Reports Third Quarter 2024 Financial Results
05/11/202422:00GLOBECytokinetics Announces Six Upcoming Presentations at the..
04/11/202423:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/11/202422:00GLOBECytokinetics Announces Inducement Grants Under Nasdaq..
01/11/202421:43EDGAR2Form 144 - Report of proposed sale of securities
31/10/202421:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202421:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/10/202421:08EDGAR2Form 144 - Report of proposed sale of securities
28/10/202421:12EDGAR2Form 144 - Report of proposed sale of securities
23/10/202422:00GLOBECytokinetics to Announce Third Quarter Results on November..
17/10/202400:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/10/202413:30GLOBECytokinetics Highlights Progress in Cardiac Myosin..
15/10/202422:32EDGAR2Form 144 - Report of proposed sale of securities
10/10/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/10/202422:08EDGAR2Form 144 - Report of proposed sale of securities
Apertura: 47,50 Min: 46,80 Max: 47,78
Chiusura: 47,15

La tua Cronologia

NASDAQ
CYTK
Cytokinetics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network